Alabama Oncology, Shelby — Alabaster, Alabama

Alabama Oncology, Shelby is a clinical research site located in Alabaster, Alabama, United States 35007.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Alabama Oncology, Shelby has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Alabaster

Browse all research sites in Alabama · View every site in Alabaster

• GSK Investigational Site
• Research Site
• Alabama Kidney Research
• Wright Clinical Research
• Pfizer Investigational Site
• 786
• Investigational Site
• Neurology Neurodiagnostic Lab
• Novo Nordisk Investigational Site
• Alabama Oncology
• Heart South Cardiovascular Group PC
• Carol M. Johnson MD, LLC

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alabama Oncology, Shelby?

Alabama Oncology, Shelby has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alabama Oncology, Shelby conducted?

Alabama Oncology, Shelby has 1 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma.

Is Alabama Oncology, Shelby accredited by Crixeo Clinical Trials?

Alabama Oncology, Shelby has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alabama Oncology, Shelby?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.